Loading clinical trials...
Loading clinical trials...
CHOP/Rituximab Followed by Maintenance Pegylated Interferon-Alpha (PEG Intron)With the Treatment of Patients With Anthracycline Naïve Indolent/Follicular Non-Hodgkin's Lymphoma
Conditions
Interventions
CHOP/Rituximab
PEG INTRON
Locations
1
United States
Unversity of Nebraska Medical Center
Omaha, Nebraska, United States
Start Date
May 23, 2001
Primary Completion Date
August 1, 2005
Completion Date
June 7, 2012
Last Updated
September 14, 2023
NCT04496349
NCT00923442
NCT04188678
NCT00179673
NCT02030834
NCT00739141
Lead Sponsor
University of Nebraska
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions